Characterization of antimicrobial histone sequences and posttranslational modifications by mass spectrometry.
about
Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventionsQuantitative proteomic analysis of histone modificationsOne-pot shotgun quantitative mass spectrometry characterization of histonesSmall-molecule-based inhibition of histone demethylation in cells assessed by quantitative mass spectrometry.Osteoclast inhibitory peptide-1 binding to the Fc gammaRIIB inhibits osteoclast differentiationStable-isotope-labeled histone peptide library for histone post-translational modification and variant quantification by mass spectrometryDrawbacks in the use of unconventional hydrophobic anhydrides for histone derivatization in bottom-up proteomics PTM analysis.Breaking the histone code with quantitative mass spectrometry.A novel role for lipid droplets in the organismal antibacterial response.Role of arginine and lysine in the antimicrobial mechanism of histone-derived antimicrobial peptidesTissue-specific expression and post-translational modification of histone H3 variants.Sulfo-NHS-SS-biotin derivatization: a versatile tool for MALDI mass analysis of PTMs in lysine-rich proteins.Filter-Aided Sample Preparation Procedure for Mass Spectrometric Analysis of Plant Histones
P2860
Q26996467-DBB392DA-176D-45DB-A7A6-DEDE603FA4E1Q30375585-1D06AAB0-30E8-4431-BB39-74FD5D34F6AEQ33560203-E462139C-D28B-4CDE-8ABB-C75CD5691F0AQ34123085-84FEBBCA-4603-4C98-BBA3-D26C6053CACCQ34132396-FE367338-A860-4213-A139-1B3D1C87A718Q34157702-2939712D-1CBF-4491-8D9A-70599CF0F5C9Q35638823-3F46F5C0-A28F-46FE-BF00-F01752B6797AQ35645008-89BC039F-30A9-478C-9756-24AC4760C1B5Q36378764-66CECC3B-5103-4E87-87D0-2ED949FA7E9CQ36463048-DB58D0D8-A209-4735-99D1-65CA84991A8BQ37041986-BC129E99-C746-497E-A2FD-22DB42376D9DQ43558245-D62B5178-3FAC-42F1-98DC-38D237AD38FCQ57073058-4AD3330F-CA40-4157-8E4C-6972C24ED7A0
P2860
Characterization of antimicrobial histone sequences and posttranslational modifications by mass spectrometry.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Characterization of antimicrob ...... ications by mass spectrometry.
@ast
Characterization of antimicrob ...... ications by mass spectrometry.
@en
Characterization of antimicrob ...... ications by mass spectrometry.
@nl
type
label
Characterization of antimicrob ...... ications by mass spectrometry.
@ast
Characterization of antimicrob ...... ications by mass spectrometry.
@en
Characterization of antimicrob ...... ications by mass spectrometry.
@nl
prefLabel
Characterization of antimicrob ...... ications by mass spectrometry.
@ast
Characterization of antimicrob ...... ications by mass spectrometry.
@en
Characterization of antimicrob ...... ications by mass spectrometry.
@nl
P356
P1476
Characterization of antimicrob ...... ications by mass spectrometry.
@en
P2093
Kevin L Schey
Séverine A Ouvry-Patat
P304
P356
10.1002/JMS.1200
P577
2007-05-01T00:00:00Z